Dose-dependent modulation of a B-cell protein signature by ianalumab in patients with Sjögren disease
Year: 2025
Type: article
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4406149214
